Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 is shown on the page. This is a minor internal update that does not affect study content or user-facing information, and To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:45:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. Revision updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:49:35.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed a funding-status disclaimer indicating potential delays due to government funding lapse; the page no longer displays operating status notes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T07:11:50.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The screenshots show the same study page with identical core content including Study Overview, eligibility criteria, and locations; no substantive data or status changes are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:23.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Overall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T10:34:07.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.0%
    Check dated 2025-09-28T03:27:47.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.